EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 16 July 2020

Key Trade Data Points on the EU27 Pharmaceutical Supply Chain

In 2019, 86.2% of EU27 imports of Human Medicinal Products came from Europe.

In this study, ECIPE has used Eurostat (2019) data to look at the imports and exports of the EU27 in value (Euro) and volume (kg) terms for the pharmaceutical sector. Statistics are reported for the overall pharmaceutical products, human medicinal products, vaccines, and antibiotics.

The main findings are that the EU27 is a strong exporter of pharmaceutical products, and in terms of imports is resilient because most come from the EU itself. China and India are not large exporters to the EU, except for China's share in APIs in volume terms (kg). But even in the latter case, total imports amount to 22.5% of all EU27 imports.
Read more

#WeWontRest in the fight against AMR

Last week, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund, a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030.

IMI Impact: tackling antimicrobial resistance together
10 July 2020

The Innovative Medicines Initiative is delivering fresh hope in the search for new antibiotics Read more

Europe’s COVID-19 response points the way to fighting AMR
16 July 2020

Antimicrobial resistance: Perspectives from a pharmaceutical SME Read more

Blogs

Europe’s cancer battle has momentum – let’s build on it
16 July 2020 - Nathalie Moll

EU institutions are stepping up the fight against cancer. The new ‘Challenge Cancer’ Intergroup can be a platform for... Read more

How biotech SMEs adapted to COVID-19: An interview with Minoryx Therapeutics
16 July 2020

As the pandemic threatened to disrupt key clinical trials, a small company responded swiftly to protect patients and... Read more

EU strategic resilience in pharmaceuticals: global value chains and innovation
15 July 2020 - Koen Berden - Elizabeth Kuiper

One concept that has been much discussed recently as a result of the COVID-19 crisis has been the need for the region... Read more

Events

Patient Engagement Open Forum
10 September 2020 (Series of virtual events)

The Patient Engagement Open Forum 2020 will go virtual with a series of virtual events from June 25th until the end... Read more

NEW DATES - EU Health Summit 2020
26 October 2020 (Virtual event)

The EU Health Coalition is delighted to announce the second edition of the EU Health Summit. Read more

Our latest publications

EFPIA code report 2019
16 July 2020 (Publications)

This annual Code Report summarises the work and activities that have taken place in connection with the implementation,... Read more

2020: The Pharmaceutical Industry in Figures
30 June 2020 (Publications)

Our annual statistics leaflet Read more

What we are reading

Reviewing orphan drugs law: A tough equation
On 06 July 2020 (Euractiv)

The Orphan Regulation was introduced in 2000 and its main objective was to address the challenge of regulating medicines... Read more

European Parliament keen to play key role in boosting actions to tackle AMR
On 14 July 2020 (The Parliament Magazine)

COVID-19 may only be a foretaste of what we could expect from a world where antimicrobials are no longer effective,... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu